Jiří Hanzlík

At Sandoz, we are discovering new ways to improve and extend people's lives and to make high-quality medicines more accessible to people around the world. While Sandoz holds global leadership in biosimilars, generic antibiotics, dermatology and transplant medicines, it is also a global leader in many other categories. In 2015, our products reached approximately 500 million patients. Thank you for respecting Sandoz's LinkedIn social media conduct policy.